Curriculum Vitae
Total Page:16
File Type:pdf, Size:1020Kb
CURRICULUM VITAE NAME: Eui-Cheol Shin, M.D., Ph.D. PLACE OF BIRTH: Seoul, Korea DATE OF BIRTH: August 29, 1971 NATIONALITY: Korean PRESENT POSITION: Associate Professor (KAIST Endowed Chair Professor), Graduate School of Medical Science & Engineering, KAIST CONTACT INFORMATION: 291 Daehak-ro, KAIST Biomedical Research Center, #4109 Daejeon 34141, Republic of Korea Tel) +82-42-350-4236 Fax) +82-42-350-4240 Mobile) +82-10-6813-8488 E-mail) [email protected] EDUCATION: 1990-1996: M.D., graduated in 1st in class, Yonsei University College of Medicine, Seoul, Korea 1996-2001: Ph.D. (in Microbiology & Immunology), Yonsei University College of Medicine, Seoul, Korea CAREER: 1999-2002: Medical Scientist, Department of Microbiology, The Armed Forces Medical Research Institute, Daejeon, Korea, (Mandatory military service) 2002-2007: Research Fellow, Immunology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA (Advisor: Barbara Rehermann, M.D.) 2007-2013: Assistant Professor, Graduate School of Medical Science and Engineering, KAIST, Daejeon, Korea 2013-present: Associate Professor, Graduate School of Medical Science and Engineering, KAIST, Daejeon, Korea 2017-present: KAIST Endowed Chair Professor, Graduate School of Medical Science and Engineering, KAIST, Daejeon, Korea 2017-present: Adjunct Professor, KI for Health Science and Technology, KAIST, Daejeon, Korea ACADEMIC ACTIVITIES: 2011-2012: Chair, Vaccine Interest Group, The Korean Association of Immunologists, Korea 2014-present: Chair, Academic Committee, The Korean Vaccine Society, Korea 2017-present: Member, Immunology working group, International Coalition to Eliminate Hepatitis B Virus (ICE-HBV) 2017-present: Organizer, 26th International Symposium on Hepatitis C Virus and Related Viruses, 2019 2010-present: Editorial Board, Frontiers in Microbiology 2011-present: Editorial Board, PLoS One - 1 - 2012-present: Editorial Board, Clinical and Experimental Medicine 2013-present: Associate Editor, Immune Network 2016-present: Associate Editor, Clinical and Experimental Vaccine Reseasrch 2007-present: Ad Hoc Reviewer, Journal of Infectious Diseases, Gastroenterology, International Immunology, Vaccine, Future Microbiology, Hepatology, Gut, Journal of Virology, Nature Communications, Scientific Reports, Frontiers in Microbiology, Journal of Immunological Methods SOCIETY MEMBERSHIP: The Korean Association of Immunologists The Korean Society of Virology The Korean Association for the Study of the Liver The Korean Society for Biochemistry and Molecular Biology The Korean Society for Molecular and Cellular Biology The American Association of Immunologists The American Association for the Study of Liver Diseases RESEARCH INTERESTS: Hepatitis Viruses, Viral Immunology, Virus-Host Interaction, Immune Aging, Human Immune Monitoring PUBLICATIONS: 1. Kim YH, Park DS, Park JH, Lee JL, Shin EC, Lee JH, Lee JM, Kim SJ: Expression of ICAM-1 and HLA-DR induced by IFN-γ in human bladder cancer cell lines. Korean J Immunol 17:17-26, 1995 2. Kwon DH, Park HW, Shin JS, Shin EC, Kim SJ, Kim JD, Choi IH: Expression of p58 in fetal thymocytes and fetal liver lymphocytes. Korean J Immunol 20:17-23, 1998 3. Chwae YJ, Choi IH, Kim DS, Shin EC, Kwon DH, Kim SJ, Kim JD: Clonal expansion of T-cells in measles. Immunol Lett 63:147-152, 1998 4. Shin EC, Shin JS, Park JH, Kim JJ, Kim H, Kim SJ: Expression of Fas-related genes in human hepatocellular carcinomas. Cancer Lett 134:155-162, 1998 5. Jiang S, Song MJ, Shin EC, Lee MO, Kim SJ, Park JH: Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fas-independent pathways. Hepatology 29:101-110, 1999 6. Choi C, Park JY, Lee J, Lim JH, Shin EC, Ahn YS, Kim CH, Kim SJ, Kim JD, Choi IS, Choi IH: Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-α, or IFN-γ. J Immunol 162:1889-1895, 1999 7. Shin EC, Shin JS, Park JH, Kim H, Kim SJ: Expression of Fas ligand in human hepatoma cell lines: role of hepatitis B virus X (HBX) in induction of Fas ligand. Int J Cancer 82:587-591, 1999 8. Shin JS, Shin EC, Kim J, Choi IH, Park JH, Kim SJ: Monoclonal antibodies with various reactivity to p58 killer inhibitory receptors. Hybridoma 18:521-527, 1999 9. Kang HJ, Song MR, Lee SK, Shin EC, Choi YH, Kim SJ, Lee JW, Lee MO: Retinoic acid and its receptors repress the expression and transactivation function of Nur77: a possible mechanism - 2 - for the inhibition of apoptosis by retinoic acid. Exp Cell Res 256:545-554, 2000 10. Shin EC, Cho SE, Lee DK, Hur MW, Paik SR, Park JH, Kim J: Expression patterns of α- synuclein in human hematopoietic cells and in Drosophila at different developmental stages. Molecules and Cells 10:65-70, 2000 11. Kim WH, Yeo M, Kim MS, Chun SB, Shin EC, Park JH, Park IS: Role of caspase-3 in apoptosis of colon cancer cells induced by nonsteroidal anti-inflammatory drugs. Int J Colorectal Dis 15:105-111, 2000 12. Jin M, Piao Z, Kim NG, Park C, Shin EC, Park JH, Jung HJ, Kim CG, Kim H: p16 is a major inactivation target in hepatocellular carcinoma. Cancer 89:60-68, 2000 13. Shin EC, Shin WC, Choi Y, Kim H, Park JH, Kim SJ: Effect of interferon-γ on the susceptibility to Fas (CD95/APO-1)-mediated cell death in human hepatoma cells. Cancer Immunol Immunother 50:23-30, 2001 14. Shin EC, Ahn JM, Kim CH, Choi Y, Ahn YS, Kim H, Kim SJ, Park JH: IFN-γ induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway. Int J Cancer 93:262-268, 2001 15. Kim HJ, Shin EC, Yoo NJ, Park JH, Kim SJ, Kang ES, Jahng JS: Apoptosis of chondrocytes and its regulation in pathogenesis of osteoarthritis. J Korean Rheumatism Assoc 8:104-117, 2001 16. Lee MO, Kang HJ, Cho H, Shin EC, Park JH, Kim SJ: Hepatitis B virus X protein induced expression of the nur77 gene. Biochem Biophys Res Commun 288:1162-1168, 2001 17. Lee MO, Choi YH, Shin EC, Kang HJ, Kim YM, Jeong SY, Seong JK, Yu DY, Cho H, Park JH, Kim SJ: Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection. J Hepatol 37:380-386, 2002 18. Shin EC, Seong YR, Kim CH, Kim H, Ahn YS, Kim K, Kim SJ, Hong SS, Park JH: Human hepatocellular carcinoma cells resist to TRAIL-induced apoptosis, and the resistance is abolished by cisplatin. Exp Mol Med 34:114-122, 2002 19. Shin EC, Choi YH, Kim JS, Kim SJ, Park JH: Expression patterns of cytokines and chemokines genes in human hepatoma cells. Yonsei Med J 43:657-664, 2002 20. Park DY, Sol MY, Suh KS, Shin EC, Kim CH: Expressions of transforming growth factor (TGF)- β1 and TGF-β type II receptor and their relationship with apoptosis during chemical hepatocarcinogenesis in rats. Hepatol Res 27:205-213, 2003 21. Shin EC, Choi KS, Kim SJ, Shin JS: Modulation of the surface expression of CD158 killer cell Ig-like receptor by interleukin-2 and transforming growth factor-β. Yonsei Med J 45:510-514, 2004 22. Farrell CJ, Lee JM, Shin EC, Cebrat M, Cole PA, Hayward SD: Inhibition of Epstein-Barr virus- induced growth proliferation by a nuclear antigen EBNA2-TAT peptide. Proc Natl Acad Sci USA 101:4625-4630, 2004 23. Nascimbeni M, Shin EC, Chiriboga L, Kleiner DE, Rehermann B: Peripheral CD4/CD8 double- positive T cells are differentiated effector memory cells with antiviral functions. Blood 104:478-486, 2004 24. Rehermann B, Shin EC: Private aspects of heterologous immunity. J Exp Med 201:667-670, 2005 (commentary) 25. Shin EC, Protzer U, Untergasser A, Feinstone SM, Rice CM, Hasselschwert D, Rehermann B: Liver-directed gamma interferon gene delivery in chronic hepatitis C. J Virol 79:13412-13420, - 3 - 2005 26. Shin EC, Rehermann B: Taking the brake off T cells in chronic viral infection. Nat Med 12:276-277, 2006 (commentary) 27. Manigold T, Shin EC, Mizukoshi E, Mihalik K, Murthy KK, Rice CM, Piccirillo CA, Rehermann B: Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C. Blood 107:4424-4432, 2006 28. Shin EC: Immunology of hepatitis C: clinical significance of T cell response. Korean J Hepatol 12:140-153, 2006 (invited review) 29. Shin EC, Seifert U, Kato T, Rice CM, Feinstone SM, Kloetzel PM, Rehermann B: Virus-induced type I interferon stimulates generation of immunoproteasomes at the site of infection. J Clin Invest 116:3006-3014, 2006 30. Shin EC, Seifert U, Urban S, Truong KT, Feinstone SM, Rice CM, Kloetzel PM, Rehermann B: Proteasome activator and antigen-processing aminopeptidases are regulated by virus-induced type I interferon in the hepatitis C virus-infected liver. J Interferon Cytokine Res 27:985-990, 2007 31. Shin EC, Capone S, Cortese R, Colloca S, Nicosia A, Folgori A, Rehermann B: The kinetics of hepatitis C virus-specific CD8 T-cell responses in the blood mirrors those in the liver in acute hepatitis C virus infection. J Virol 82:9782-9788, 2008 32. Mix H, Weiler-Normann C, Thimme R, Ahlenstiel G, Shin EC, Herkel J, David CS, Lohse AW, Rehermann B: Identification of CD4 T cell epitopes in soluble liver antigen / liver pancreas autoantigen in autoimmune hepatitis. Gastroenterology 135:2107-2118, 2008 33. Chang DY, Shin EC: Immune-based therapy for chronic hepatitis C. J Leukoc Biol 86:33-39, 2009 (invited review) 34. Lee J, Suh WI, Shin EC: T-cell dysfunction and inhibitory receptors in hepatitis C virus infection. Immune Netw 10:120-125, 2010 (invited review) 35.